| Patents for C07K 9 - Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof (3,306) |
|---|
| 05/27/2004 | WO2004044223A2 Prodrugs of vancomycin with hydrolysis resistant polymer linkers |
| 05/27/2004 | WO2004044222A2 Polymeric prodrugs of vancomycin |
| 05/27/2004 | WO2004016274B1 Novel peptide-conjugated oligomeric compounds |
| 05/27/2004 | US20040102607 Trimeric antigenic O-linked glycopeptide conjugates, methods of preparation and uses thereof |
| 05/21/2004 | WO2004041203A2 Gemcitabine prodrugs, pharmaceutical compositions and uses thereof |
| 05/21/2004 | WO2004041194A2 Inhibition of hiv-1 replication |
| 05/19/2004 | EP1419174A2 Process for preparing glycopeptide derivatives |
| 05/19/2004 | EP1418933A2 Process for preparing glycopeptide phosphonate derivatives |
| 05/18/2004 | US6737403 Culturing microorganism streptomyces viridochromogenes, ssp. komabensis (atcc 29814) in culture medium, isolating laspartomycin, cleaving lipophilic fragment from laspartomycin, thereby yielding laspartomycin core peptide |
| 05/18/2004 | CA2248139C Methods of alleviating neuropathic pain using prosaposin-derived peptides |
| 05/12/2004 | EP1417223A1 Process for preparing lipid ii |
| 05/12/2004 | EP1084409B1 Method and device for electrochemical immunoassay of multiple analytes |
| 05/06/2004 | US20040087494 Glycopeptide carboxy-saccharide derivatives |
| 04/29/2004 | WO2004035605A2 Glycoprotein synthesis |
| 04/29/2004 | WO2002043771A9 Conjugates of glycosylated/galactosylated peptide |
| 04/29/2004 | US20040082026 Viricides; heptatis virus; complexing of interferon with glycan |
| 04/29/2004 | CA2500653A1 Glycoprotein synthesis |
| 04/27/2004 | US6727232 Nucleoside peptide antibiotics of AA-896 |
| 04/22/2004 | US20040077836 Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF |
| 04/22/2004 | US20040077826 Randomly generated glycopeptide combinatorial libraries |
| 04/21/2004 | EP1411063A1 Peptide nucleic acids |
| 04/15/2004 | US20040072758 Contulakin-G, analogs thereof and uses therefor |
| 04/14/2004 | CN1489477A Conjugates of glycosylated/galactosylated peptide, bifunctional linker and nucleotidic monomers/polymers, and related compositions and method of use |
| 04/06/2004 | US6716962 Contacting the antibiotic with a divalent metal ion and an organic solvent, to extract the lipopeptide antibiotic into the solvent; and contacting the extract of the lipopeptide antibiotic with acid. |
| 04/01/2004 | WO2004026894A2 Synthesis and characterization of novel systems for guidance and vectorization of compounds having a therapeutic activity |
| 04/01/2004 | US20040063916 Bactericides; antibiotics |
| 04/01/2004 | US20040063911 Genetic engineering; using glycosyltransferases |
| 04/01/2004 | US20040063623 Formulation of boronic acid compounds |
| 03/31/2004 | CN1143859C Camptothecin derivative and its preparation |
| 03/30/2004 | US6713448 Substantially pure glycopeptide antibiotics AC-98-1; AC-98-2; AC-98-3; AC-98-4 and AC-98-5 |
| 03/30/2004 | US6713446 Boronic acid compounds obtained by lyophilization of an aqueous mixture of the boronic acid compound and a sugar having at least two hydroxyl groups; shelf life |
| 03/25/2004 | WO2004016274A3 Novel peptide-conjugated oligomeric compounds |
| 03/25/2004 | US20040059087 Peptide nucleic acids |
| 03/25/2004 | US20040058859 Multiple antigen glycopeptide carbohydrate vaccine comprising the same and use thereof |
| 03/24/2004 | EP1399176A1 Substantially pure glycopeptide antibiotics ac-98-1; ac-98-2; ac-98-3; ac-98-4 and ac-98-5 |
| 03/23/2004 | US6710168 Vancomycin derivatives |
| 03/23/2004 | US6710163 Compounds that bind single-stranded dna and rna strands to form stable hybrids; bind complementary single-stranded dna and rna strands more strongly than corresponding dna |
| 03/18/2004 | WO2004022578A2 Methods, compositions and libraries pertaining pna dimer and pna oligomer synthesis |
| 03/18/2004 | US20040054128 Method of synthesis of beta-thiolato cobalamin compounds |
| 03/18/2004 | CA2495895A1 Methods, compositions and libraries pertaining pna dimer and pna oligomer synthesis |
| 03/11/2004 | WO2004019970A2 Glycopeptide antibiotic and semisynthetic derivatives thereof and their use as antiviral agents |
| 03/11/2004 | WO2003099862A8 Export and modification of (poly)peptides in the lantibiotic way |
| 03/11/2004 | WO2003042247A3 Modified anti-tnf alpha antibody |
| 03/11/2004 | CA2497159A1 Glycopeptide antibiotic and semisynthetic derivatives thereof and their use as antiviral agents |
| 03/04/2004 | US20040043446 Cell-free in vitro method of remodeling a peptide molecule, including the addition or deletion of one or more glycosyl groups to a peptide, and/or the addition of a modifying group to a peptide; treatment of Fabry disease |
| 03/02/2004 | US6699836 Vancomycin analogs |
| 03/02/2004 | US6699835 Formulation of boronic acid compounds |
| 02/26/2004 | WO2004016274A2 Novel peptide-conjugated oligomeric compounds |
| 02/26/2004 | US20040038274 Gapped 2' modified oligonucleotides |
| 02/25/2004 | EP1390521A1 Glycopeptide antibiotics |
| 02/25/2004 | EP1390056A2 Glycopeptide antibiotics |
| 02/24/2004 | US6696408 Administering glycosylated polypeptides as antiepileptics and anticonvulsants or for prophylaxis of psychological disorders |
| 02/19/2004 | WO2003032925A3 Glycosulfopeptide inhibitors and methods of use thereof |
| 02/19/2004 | US20040034191 Novel peptide-conjugated oligomeric compounds |
| 02/19/2004 | US20040033939 Cross-linked glycopeptide-cephalosporin antibiotics |
| 02/12/2004 | US20040027537 Continuous two-dimensional corneal topography target |
| 02/11/2004 | CN1137899C 17,21-ester substituted 1,4-diene-3-keto-9,11-epoxy-steroid compound |
| 02/10/2004 | US6689763 Antibiotics AA-896 |
| 02/05/2004 | WO2004011479A1 Inhibitors of rna dependent rna polymerase and uses thereof |
| 02/05/2004 | WO2004011476A1 Glyconjugates comprising carbohydrate epitopes, methods for theirsynthesis, and their use for the treatment or prophylaxis of cancer |
| 02/05/2004 | US20040024177 Method for purifying teicoplanin A2 |
| 02/04/2004 | CN1472221A Method for purifying teicoplanin by analog moving bed chromospheric separation |
| 02/03/2004 | CA2182244C Camptothecin derivatives |
| 01/29/2004 | WO2003015709A3 Bifunctional glycopeptides antibiotics and combinatorial libraries thereof |
| 01/28/2004 | EP1383480A2 Lipid-comprising drug delivery complexes and methods for their production |
| 01/22/2004 | US20040014964 Vitronectin receptor antagonist pharmaceuticals |
| 01/15/2004 | WO2004005330A1 Process for producing sugar peptide having asparagine sugar chain and the sugar peptide |
| 01/15/2004 | US20040009550 Export and modification of (poly)peptides in the lantibiotic way |
| 01/15/2004 | CA2822657A1 Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides |
| 01/15/2004 | CA2491594A1 Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides |
| 01/13/2004 | US6676946 Dendrimeric polylysine having bonded epitopes; cancer immuno-therapy |
| 01/08/2004 | US20040006007 Methods and compositions for treating hepatitis C virus using 4'-modified nucleosides |
| 12/31/2003 | WO2004000802A2 Scaffolded maleimide clusters for multivalent peptide assembly |
| 12/31/2003 | CA2490124A1 Scaffolded maleimide clusters for multivalent peptide assembly |
| 12/30/2003 | US6670446 N1 modified glycopeptides |
| 12/11/2003 | US20030229014 Agents and methods for promoting bone growth |
| 12/09/2003 | US6660714 α-O-linked glycoconjugates, methods of preparation and uses thereof |
| 12/09/2003 | US6660267 Prevention and treatment of sepsis |
| 12/04/2003 | WO2003099862A1 Export and modification of (poly)peptides in the lantibiotic way |
| 12/04/2003 | WO2003099858A1 Cross-linked glycopeptide-cephalosporin antibiotics |
| 12/04/2003 | WO2003045980A3 Glycopeptide remodeling using amidases |
| 12/04/2003 | US20030224975 Glycopeptide antibacterial compounds, compositions containing same and methods of using same |
| 12/04/2003 | CA2487351A1 Export and modification of (poly)peptides in the lantibiotic way |
| 11/27/2003 | WO2003070756A3 Novel glycopeptide antibiotics and method for synthesis thereof |
| 11/27/2003 | WO2003046150A3 Glycoprotein remodeling using endoglycanases |
| 11/27/2003 | WO2003018607A3 Process for preparing glycopeptide derivatives |
| 11/27/2003 | US20030219830 Preparing polysaccharide conjugated glycoproteins for use as drug delivery tools in human therapeutics |
| 11/20/2003 | WO2002085310A3 Antibiotics aa-896 |
| 11/13/2003 | US20030211979 FAP-activated anti-tumor compounds |
| 11/12/2003 | EP1360189A1 Formulation of boronic acid compounds |
| 11/11/2003 | US6645935 Synthesis of glycoconjugates of the lewis Y epitope and uses thereof |
| 11/06/2003 | WO2003026589A3 Methods and compositions for treating hepatitis c virus using 4'-modified nucleosides |
| 11/06/2003 | US20030207797 Glycopeptides that are substituted with one or more substituents each comprising one or more phosphono groups; and pharmaceutical compositions containing such glycopeptide derivatives. The disclosed glycopeptide derivatives are useful |
| 10/30/2003 | WO2001057071A3 Glycopeptide derivatives having antibiotic activity |
| 10/30/2003 | US20030203865 Lipid-comprising drug delivery complexes and methods for their production |
| 10/29/2003 | EP1355920A1 Extractive purification of lipopeptide antibiotics |
| 10/29/2003 | EP1355910A1 Formulation of boronic acid compounds |
| 10/29/2003 | EP1355672A2 Conjugates of glycosylated/galactosylated peptide, bifunctional linker, and nucleotidic monomers/polymers, and related compositions and methods of use |
| 10/23/2003 | WO2003086475A1 Conjugates comprising cancer cell specific ligands, a sugar and diagnostic agents, and uses thereof |
| 10/23/2003 | WO2001079267A9 A glycopeptide and preparation thereof |